Tsingke Biotech和iGeneTech伙伴利用人工智能和可缩放基因生产促进精密医学、农业以及基因编辑的合成生物学。 Tsingke Biotech and iGeneTech partner to boost synthetic biology for precision medicine, agriculture, and gene editing using AI and scalable gene production.

北京Tsingke生物科技与iGeneTech(iGeneTech)结成了推动合成生物学的战略伙伴关系,将Tsingke的高通量基因合成与iGeneTech(iGeneTech)的基因采集和测序专长结合起来。 Beijing-based Tsingke Biotech and iGeneTech have formed a strategic partnership to advance synthetic biology, combining Tsingke’s high-throughput gene synthesis with iGeneTech’s gene capture and sequencing expertise. 在北京宣布的合作旨在加速精密医学、农业和基因编辑方面的创新,通过人工智能驱动的制造业和可扩缩的寡头生产等综合技术进行。 The collaboration, announced in Beijing, aims to accelerate innovation in precision medicine, agriculture, and gene editing through integrated technologies like AI-driven manufacturing and scalable oligo production. 这些公司正在开发一种简化的工作流程,从基因合成到现实世界应用,强调效率和可持续性,以满足生物制药、食品和环境部门日益增长的需求。 The companies are developing a streamlined workflow from gene synthesis to real-world applications, emphasizing efficiency and sustainability to meet growing demand across biopharma, food, and environmental sectors.